Champions Oncology, Inc. (CSBR) vs iBio, Inc. (IBIO)
A side-by-side comparison of Champions Oncology, Inc. and iBio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CSBR
Champions Oncology, Inc.
$4.99HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
IBIO
iBio, Inc.
$1.09HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
Total return — CSBR vs IBIO
growth of $100 · dividends reinvested · last 10yCSBR +208.7% (+11.9%/yr)IBIO -100.0% (-54.1%/yr)CSBR compounded faster over this window
Log scale — wide-divergence pair
CSBR IBIO
CSBR vs IBIO: by the numbers
- •IBIO is the larger company ($70M vs $69M market cap).
- •Both run net losses; CSBR's is the smaller (-1.87% vs -33044.00% net margin).
- •CSBR grew revenue faster over the past five years (7.25% vs -46.91% CAGR).
Metrics side by side
Valuation
| Metric | CSBR | IBIO |
|---|---|---|
| Forward P/E | 49.90 | N/A |
| P/S ratio | 1.14 | 700.95 |
| P/B ratio | 17.81 | 0.82 |
| EV / EBITDA | 260.97 | N/A |
Profitability
| Metric | CSBR | IBIO |
|---|---|---|
| Gross margin | 49.30% | 100.00% |
| Operating margin | -1.72% | -35141.00% |
| Net margin | -1.87% | -33044.00% |
| ROE | -29.15% | -38.55% |
| ROIC | -6.75% | -40.22% |
Growth (annualized)
| Metric | CSBR | IBIO |
|---|---|---|
| Revenue CAGR (5Y) | 7.25% | -46.91% |
| Total return CAGR (5Y) | -13.07% | -70.43% |
Frequently asked
- Which has grown faster, CSBR or IBIO?
- Over the past five years, CSBR grew revenue faster — CSBR at a 7.25% CAGR versus IBIO at -46.91%.
- How have CSBR and IBIO total returns compared?
- Over the past 10 years, CSBR delivered 12.07% and IBIO delivered -54.11% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.